Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SKB571 in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
NCT07668154Phase 2Recruiting
- Sponsor
- Kelun-Biotech
- Start
- Jul 2026
- Primary completion
- Sep 2028
- Countries
- 1
01
Overview
A Phase 2 trial of SKB571 in head and neck squamous cell carcinoma (HNSCC), sponsored by Kelun-Biotech. Started Jul 2026; status: recruiting.
02
Drugs
SKB571
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT07668154.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07668154.